Andrew Bowden

On the record
Represented by:

Andrew guides the strategic direction of the company and is the main point of contact with the board of directors, management team, and operations. Since his appointment to CEO at the start of the Company’s 2020 fiscal year, Item 9 Labs Corp. has seen strong, steady performance with sequential quarter-over-quarter growth rates around 20%.

Recent Quotes
Sign up to view all
  • Dispensary ownership is a lucrative opportunity, but it comes with a considerable amount of challenges to navigate. The combination of our brands are the solution.

    1 April 2022